
|Articles|July 13, 2023
Skyelarke Announces New Enhancements to Patient Payment Platform, SkyePay
Advertisement
Skyelarke has announced new additions to SkyePay, a patient payment technology.
With the launch of faster payments via bank transfer, virtual cards, and PayPal/Venmo integration, on top of the physical card option, SkyePay is now providing patients with more options around how they receive their expense or stipend payments related to clinical trial participation.
In addition to increased patient payment choice, SkyePay has also developed an API framework, soon to be released, which will allow IRT, EDC, or ePRO integration.
Key benefits of the SkyePay platform include:
- For patients: automated and fast payments, multiple payment methods (bank transfer, card, and virtual), and reduced financial burden.
- For sites: no training required, ability to make fast payments, integrated receipt management, and sponsor/CRO approval process.
- For sponsors/CROs: transaction reporting for reconciliation purposes, fast approval processes, and privacy by design with data stored depending on where the study is.
Reference
Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements. (2023, July 11). Cision PR Newswire.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
2
Data Quality Across the Clinical Trial Lifecycle: What It Takes to Fully Trust Your Data
3
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
4
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
5




